197 related articles for article (PubMed ID: 1567393)
1. Stimulation of osteoclastic bone resorption by hydrogen peroxide.
Bax BE; Alam AS; Banerji B; Bax CM; Bevis PJ; Stevens CR; Moonga BS; Blake DR; Zaidi M
Biochem Biophys Res Commun; 1992 Mar; 183(3):1153-8. PubMed ID: 1567393
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
McSheehy PM; Chambers TJ
J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
[TBL] [Abstract][Full Text] [Related]
3. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.
Chambers TJ; McSheehy PM; Thomson BM; Fuller K
Endocrinology; 1985 Jan; 116(1):234-9. PubMed ID: 3880540
[TBL] [Abstract][Full Text] [Related]
4. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
Hall TJ; Schaeublin M; Chambers TJ
Biochem Biophys Res Commun; 1993 Sep; 195(3):1245-53. PubMed ID: 8216256
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3/parathormone affect fetal osteoclastic bone resorption in vivo.
Rebut-Bonneton C; Marie PJ; Demignon J; Hott M
Horm Metab Res; 1985 Sep; 17(9):483-4. PubMed ID: 3840116
[No Abstract] [Full Text] [Related]
6. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
Lorenzo JA; Raisz LG; Hock JM
J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
[TBL] [Abstract][Full Text] [Related]
7. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
Rao LG; Krishnadev N; Banasikowska K; Rao AV
J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae.
Fraser JH; Helfrich MH; Wallace HM; Ralston SH
Bone; 1996 Sep; 19(3):223-6. PubMed ID: 8873962
[TBL] [Abstract][Full Text] [Related]
9. Effect of pH on bone resorption by rat osteoclasts in vitro.
Arnett TR; Dempster DW
Endocrinology; 1986 Jul; 119(1):119-24. PubMed ID: 3720660
[TBL] [Abstract][Full Text] [Related]
10. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
[TBL] [Abstract][Full Text] [Related]
12. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
Azuma Y; Sato H; Oue Y; Okabe K; Ohta T; Tsuchimoto M; Kiyoki M
Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053
[TBL] [Abstract][Full Text] [Related]
13. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
McSheehy PM; Chambers TJ
Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of bone resorption and collagen synthesis in neonatal mouse calvaria.
Hefley TJ; Krieger NS; Stern PH
Anal Biochem; 1986 Feb; 153(1):166-71. PubMed ID: 3457544
[TBL] [Abstract][Full Text] [Related]
16. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
Woo JT; Kasai S; Stern PH; Nagai K
J Bone Miner Res; 2000 Apr; 15(4):650-62. PubMed ID: 10780857
[TBL] [Abstract][Full Text] [Related]
17. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
Alam AS; Gallagher A; Shankar V; Ghatei MA; Datta HK; Huang CL; Moonga BS; Chambers TJ; Bloom SR; Zaidi M
Endocrinology; 1992 Jun; 130(6):3617-24. PubMed ID: 1597159
[TBL] [Abstract][Full Text] [Related]
18. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
Morony S; Capparelli C; Lee R; Shimamoto G; Boone T; Lacey DL; Dunstan CR
J Bone Miner Res; 1999 Sep; 14(9):1478-85. PubMed ID: 10469275
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption.
Suhr SM; Pamula S; Baylink DJ; Lau KH
J Bone Miner Res; 2001 Oct; 16(10):1795-803. PubMed ID: 11585343
[TBL] [Abstract][Full Text] [Related]
20. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
